The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ho, O.
Right arrow Articles by Green, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, O.
Right arrow Articles by Green, W. R.
The Journal of Immunology, 2006, 176: 2470-2475.
Copyright © 2006 by The American Association of Immunologists

Cytolytic CD8+ T Cells Directed against a Cryptic Epitope Derived from a Retroviral Alternative Reading Frame Confer Disease Protection1

On Ho* and William R. Green2,*,{dagger}

* Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, NH 03756; and {dagger} Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756

Cytolytic CD8+ T cells (CTL) are key to the immune response that controls virus infections and mediates disease protection. The ability of CTL to induce apoptosis of infected cells and/or limit viral replication is determined by recognition of processed viral peptide epitopes on the surface of the target cell. An understudied source of MHC class I-presented peptides is the aptly named "cryptic epitopes," defined by their nontraditional methods of generation, including derivation from alternative reading frames (ARFs). Although ARF-encoded epitopes have now been documented in a few systems, their potential functional relevance in vivo has been debated. In this study, we demonstrate the physiological significance of an ARF-derived CTL epitope in a retrovirus-induced disease model. We show that disease-susceptible CD8-deficient mice reconstituted with CTL specific for the retroviral ARF-derived SYNTGRFPPL epitope controlled an infection by the LP-BM5 retrovirus isolate, evidently at the level of viral clearance, resulting in protection of these mice from disease. These data indicate that ARF-derived epitopes are indeed relevant inducers of the immune system and demonstrate the importance of atypically generated peptides as functional Ag with a physiologic role in disease protection.




This article has been cited by other articles:


Home page
CVIHome page
K. E. Garrison, S. Champiat, V. A. York, A. T. Agrawal, E. G. Kallas, J. N. Martin, F. M. Hecht, S. G. Deeks, and D. F. Nixon
Transcriptional Errors in Human Immunodeficiency Virus Type 1 Generate Targets for T-Cell Responses
Clin. Vaccine Immunol., September 1, 2009; 16(9): 1369 - 1371.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. A. Green, T. Okazaki, T. Honjo, W. J. Cook, and W. R. Green
The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome
J. Virol., March 1, 2008; 82(5): 2456 - 2469.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. J. Maness, L. E. Valentine, G. E. May, J. Reed, S. M. Piaskowski, T. Soma, J. Furlott, E. G. Rakasz, T. C. Friedrich, D. A. Price, et al.
AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape
J. Exp. Med., October 29, 2007; 204(11): 2505 - 2512.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Ho and W. R. Green
Alternative Translational Products and Cryptic T Cell Epitopes: Expecting the Unexpected
J. Immunol., December 15, 2006; 177(12): 8283 - 8289.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. B. Zook, M. T. Howard, G. Sinnathamby, J. F. Atkins, and L. C. Eisenlohr
Epitopes Derived by Incidental Translational Frameshifting Give Rise to a Protective CTL Response.
J. Immunol., June 1, 2006; 176(11): 6928 - 6934.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.